Carnitine and sports medicine: Use or abuse?

被引:45
作者
Brass, EP [1 ]
机构
[1] Univ Calif Los Angeles, Harbor Ctr Clin Pharmacol, Torrance, CA 90502 USA
来源
CARNITINE: THE SCIENCE BEHIND A CONDITIONALLY ESSENTIAL NUTRIENT | 2004年 / 1033卷
关键词
carnitine; exercise; homeostasis; metabolism; skeletal muscle; supplementation;
D O I
10.1196/annals.1320.006
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Carnitine has important roles in skeletal muscle bioenergetics. Skeletal muscle carnitine deficiency is associated with profound impairment of muscle function. It has thus been natural to ask if carnitine supplementation can improve skeletal muscle function and athletic performance in healthy individuals. Oral carnitine doses of several grams cause no significant clinical toxicity, further encouraging the use or carnitine as a supplement. Despite this strong foundation and 20 years of research. no compelling evidence exists that carnitine supplementation can improve physical performance in healthy subjects. The available data have been reviewed in recent publications. Several key issues are relevant to a potential therapeutic benefit or carnitine supplementation, and addressing these may. provide insight into trials of carnitine therapy in healthy subjects: (1) Can carnitine supplementation increase skeletal muscle carnitine content in healthy subjects? Muscle carnitine content is not easily increased with carnitine supplementation. This reflects both the systemic pharmacokinetics of carnitine and the systems controlling transmembrane transport of carnitine in skeletal muscle. (2) How much carnitine is required to support optimal metabolism in skeletal muscle? Data are not available to definitively define the relationship between muscle carnitine content and muscle metabolic function. Extrapolation of data from several models suggests that very low amounts of carnitine are required to support muscle function. (3) Does carnitine supplementation after energy homeostasis in healthy subjects? Several. but not all, studies suggest that subjects on carnitine supplementation have altered regulation of fuel homeostasis. However. the mechanisms or these changes, the tissues affected, and the relevance or these phenomena to exercise performance are all ill defined. (4) How can changes in performance be assessed in healthy subjects? Most studies have failed to demonstrate an objective performance. improvement in healthy subjects taking carnitine. However, these negative studies must be interpreted with caution. Performance studies in athletes are conducted against a background of aggressive training regimens and nutritional interventions. Small changes. which may be very important to the athlete, may be very, hard to objectify in the laboratory. Assessments must differentiate between changes in maximal aerobic capacity, ability to sustain effort at varied workloads, and the subject's perception or exertion. The interaction of carnitine supplementation with exercise training may be particularly important on theoretical and experimental bases. Systematic research in each of these areas is required to better understand the physiology, biochemistry. and pharmacology of carnitine supplementation. While data do not allow a conclusion to be drawn that carnitine is beneficial, the negative has not been proven either.
引用
收藏
页码:67 / 78
页数:12
相关论文
共 52 条
[1]   CARNITINE IN MUSCLE, SERUM, AND URINE OF NONPROFESSIONAL ATHLETES - EFFECTS OF PHYSICAL EXERCISE, TRAINING, AND L-CARNITINE ADMINISTRATION [J].
ARENAS, J ;
RICOY, JR ;
ENCINAS, AR ;
POLA, P ;
DIDDIO, S ;
ZEVIANI, M ;
DIDONATO, S ;
CORSI, M .
MUSCLE & NERVE, 1991, 14 (07) :598-604
[2]   Does exercise training interfere with the effects of L-carnitine supplementation? [J].
Bacurau, RFP ;
Navarro, F ;
Bassit, RA ;
Meneguello, MO ;
Santos, RVT ;
Almeida, ALR ;
Rosa, LFBPC .
NUTRITION, 2003, 19 (04) :337-341
[3]   EFFECT OF L-CARNITINE SUPPLEMENTATION ON MUSCLE AND BLOOD CARNITINE CONTENT AND LACTATE ACCUMULATION DURING HIGH-INTENSITY SPRINT CYCLING [J].
BARNETT, C ;
COSTILL, DL ;
VUKOVICH, MD ;
COLE, KJ ;
GOODPASTER, BH ;
TRAPPE, SW ;
FINK, WJ .
INTERNATIONAL JOURNAL OF SPORT NUTRITION, 1994, 4 (03) :280-288
[4]   Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist [J].
Beaumont, K ;
Webster, R ;
Gardner, I ;
Dack, K .
CURRENT DRUG METABOLISM, 2003, 4 (06) :461-485
[5]   Characterization of L-carnitine transport into rat skeletal muscle plasma membrane vesicles [J].
Berardi, S ;
Stieger, B ;
Hagenbuch, B ;
Carafoli, E ;
Krähenbühl, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (07) :1985-1994
[6]   L-carnitine stimulation of mitochondrial oxidative phosphorylation rate in isolated rat skeletal muscle mitochondria [J].
Berthon, P ;
VanDerVeer, M ;
Denis, C ;
Freyssenet, D .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 1997, 117 (01) :141-145
[7]   Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil [J].
Brass, EP ;
Mayer, MD ;
Mulford, DJ ;
Stickler, TK ;
Hoppel, CL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) :338-347
[8]   Pivalate-generating Prodrugs and carnitine homeostasis in man [J].
Brass, EP .
PHARMACOLOGICAL REVIEWS, 2002, 54 (04) :589-598
[9]   PHARMACOKINETIC CONSIDERATIONS FOR THE THERAPEUTIC USE OF CARNITINE IN HEMODIALYSIS-PATIENTS [J].
BRASS, EP .
CLINICAL THERAPEUTICS, 1995, 17 (02) :176-185
[10]  
Brass EP, 2000, AM J CLIN NUTR, V72, p618S, DOI 10.1093/ajcn/72.2.618S